{"prediction": {"id": "d4900b1d-3e64-5980-99bb-8ff59a76092b", "work_id": "230a0a64-43f3-53a3-8541-2669ec7d2f4b", "study_id": "1e6df6a9-baa1-58c0-b9ae-a094d506de5e", "kind": "Model evaluation", "pages": [3, 5], "version": "Version of record", "source_work_id": "230a0a64-43f3-53a3-8541-2669ec7d2f4b", "title": "Simulation of clinical trials of oral treprostinil in pulmonary arterial hypertension using a virtual population.", "doi": "10.1038/s41540-024-00481-y", "pdf_sha256": "6f92cb242899348d255bc551e9e663a85e186b7feb1396d1467e6523679b2da2", "physical_page_count": 11}, "fields": {"concrete_comparator": {"value": "virtual FREEDOM-M trial treatment-placebo effect versus the published clinical FREEDOM-M treatment-placebo effect", "source_basis": "original_pdf_review", "pages": [3]}, "endpoint": {"value": "six_minute_walk_distance__between_group_treatment_effect", "source_basis": "verified_profile", "pages": [3, 5]}, "family": {"value": "clinical_outcomes", "source_basis": "verified_profile", "pages": [3, 5]}, "measured_variable": {"value": "six_minute_walk_distance", "source_basis": "verified_profile", "pages": [3, 5]}, "metric": {"value": "between_group_treatment_effect", "source_basis": "verified_profile", "pages": [3, 5]}, "reference_type": {"value": "observed_clinical_reference", "source_basis": "original_pdf_review", "pages": [1, 5]}, "reported_time_window": {"value": "week 12 treatment-effect assessment in the clinical and sampled FREEDOM-M virtual trials", "source_basis": "original_pdf_review", "pages": [5]}, "role": {"value": "simulated_output", "source_basis": "verified_profile", "pages": [3, 5]}, "scenario": {"value": "simulated_trial_and_published_cohort_comparison", "source_basis": "verified_profile", "pages": [3, 5]}}, "endpoints": [{"term": "treatment_effect", "label": "Treatment response and effect measures"}], "validations": [{"id": "ccdd028b-f857-50d1-ac2e-e10699f2fdb4", "claim_id": "d4900b1d-3e64-5980-99bb-8ff59a76092b", "coverage": "direct_comparison", "support": "partial_support", "source": "unknown", "overlap": "unknown", "comparability": "partial", "statistics": "not_applicable", "anchors": [{"work_id": "230a0a64-43f3-53a3-8541-2669ec7d2f4b", "version": "Version of record", "pages": [3, 5]}]}], "model_resources": {"total": 1, "page": 1, "limit": 50, "rows": [{"id": 561, "work_id": "230a0a64-43f3-53a3-8541-2669ec7d2f4b", "claim_id": "d4900b1d-3e64-5980-99bb-8ff59a76092b", "kind": "model", "label": "Pulmonary arterial hypertension virtual-trial QSP model implementation", "repository": "Corresponding author", "identifier": "Study code request", "source_page": 10, "availability": "author_reported_restricted", "url": null, "scope": "claim_specific", "resource_version": null, "version_basis": null, "repository_commit": null, "repository_member": null, "source_file_sha256": null, "source_basis": "legacy_curated_resource", "priority": 2, "doi": "10.1038/s41540-024-00481-y", "title": "Simulation of clinical trials of oral treprostinil in pulmonary arterial hypertension using a virtual population.", "version": "Version of record", "pdf_sha256": "6f92cb242899348d255bc551e9e663a85e186b7feb1396d1467e6523679b2da2", "association_scope": "prediction", "resource_relation": "indexed_resource", "source_review": {"indexed": true, "source_basis": "legacy_curated_resource"}}], "review_status": "indexed_source"}}